Revenue of anti-diabetes drugs in the Middle East and North Africa region from 2016 to 2028 (in billion U.S. dollars)
Other statistics that may interest you Diabetes in the Middle East and North Africa region
Global overview
7
- Premium Statistic Leading health problems worldwide 2024
- Premium Statistic Diabetics worldwide 2021, 2030, and 2045
- Basic Statistic Prevalence of diabetes worldwide by region 2021 and 2045
- Basic Statistic Number of diabetes deaths worldwide 2021, by region
- Basic Statistic Global healthcare expenditure due to diabetes in 2007, 2021, 2030, and 2045
- Premium Statistic Average cost per person with diabetes globally by region 2021
- Basic Statistic Consumption of anti-diabetic drugs by select country 2022
Prevalence of diabetes in MENA
6
- Premium Statistic Age-adjusted prevalence of diabetes MENA in selected years 2000-2045
- Premium Statistic Number of adults with diabetes MENA 2021, by country
- Premium Statistic Children and adolescents with Type 1 diabetes MENA in selected years 2000-2021
- Premium Statistic Number of prediabetic adults MENA in selected years 2011-2045, by type
- Premium Statistic Share of adults with undiagnosed diabetes MENA 2021, by country
- Premium Statistic Number of diabetes related deaths MENA 2021, by country
Prevalence of obesity in MENA
8
- Premium Statistic Obesity rate among adult male MENA 2022, by country
- Premium Statistic Obesity rate among adult females MENA 2022, by country
- Premium Statistic Obesity rate among boys MENA 2022, by country
- Premium Statistic Obesity rate among girls MENA 2022, by country
- Premium Statistic Weight class of adult respondents Saudi Arabia 2023, by gender
- Premium Statistic Rate of obesity Saudi Arabia 2023, by age and gender
- Premium Statistic Weight class of children respondents Saudi Arabia 2023, by gender
- Premium Statistic Share of children with obesity Saudi Arabia 2023, by age group and gender
Diabetes medication and spending in MENA
7
- Premium Statistic Top therapy classes by spending global market 2027 forecast
- Premium Statistic Total diabetes-related health expenditure MENA in selected years 2000-2045
- Premium Statistic Cost per person with diabetes MENA 2021, by country
- Premium Statistic Revenue of diabetes care devices MENA 2017-2029
- Premium Statistic Revenue of anti-diabetes drugs MENA 2016-2028
- Premium Statistic Revenue of anti-diabetes drugs in Saudi Arabia 2017-2029
- Premium Statistic Market share of diabetes drugs Saudi Arabia 2022, by brand
Further Content: You might find this interesting as well
Statista. (March 28, 2024). Revenue of anti-diabetes drugs in the Middle East and North Africa region from 2016 to 2028 (in billion U.S. dollars) [Graph]. In Statista. Retrieved November 05, 2024, from https://www.statista.com/forecasts/1459224/mena-revenue-of-anti-diabetes-drugs
Statista. "Revenue of anti-diabetes drugs in the Middle East and North Africa region from 2016 to 2028 (in billion U.S. dollars)." Chart. March 28, 2024. Statista. Accessed November 05, 2024. https://www.statista.com/forecasts/1459224/mena-revenue-of-anti-diabetes-drugs
Statista. (2024). Revenue of anti-diabetes drugs in the Middle East and North Africa region from 2016 to 2028 (in billion U.S. dollars). Statista. Statista Inc.. Accessed: November 05, 2024. https://www.statista.com/forecasts/1459224/mena-revenue-of-anti-diabetes-drugs
Statista. "Revenue of Anti-diabetes Drugs in The Middle East and North Africa Region from 2016 to 2028 (in Billion U.S. Dollars)." Statista, Statista Inc., 28 Mar 2024, https://www.statista.com/forecasts/1459224/mena-revenue-of-anti-diabetes-drugs
Statista, Revenue of anti-diabetes drugs in the Middle East and North Africa region from 2016 to 2028 (in billion U.S. dollars) Statista, https://www.statista.com/forecasts/1459224/mena-revenue-of-anti-diabetes-drugs (last visited November 05, 2024)
Revenue of anti-diabetes drugs in the Middle East and North Africa region from 2016 to 2028 (in billion U.S. dollars) [Graph], Statista, March 28, 2024. [Online]. Available: https://www.statista.com/forecasts/1459224/mena-revenue-of-anti-diabetes-drugs